Free Newsletter
Pharma needs new blood to re-invent itself
The pharma industry should be re-inventing itself, "not re-trenching," the Association of the British Pharmaceutical Industry's director general, Dr. Richard Barker, said at the Economist conference this week. A key element of that re-invention? Bringing new talent into the insular pharma world from outside the industry. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: